MedTrace Logo

Strategies for Revascularization in Patients Undergoing Heart Valve Surgery With Concomitant Coronary Artery Disease

NCT02173860 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 502

Last updated 2016-10-21

No results posted yet for this study

Summary

The purpose of this study is to determine whether, in patients undergoing elective valvular heart surgery, revascularization of concomitant coronary artery disease (CAD) guided by FFR (Fractional flow reserve) would be superior to standard angiography-guided-revascularization approach on major efficacy and safety outcomes

Conditions

Interventions

PROCEDURE

FFR-guided surgical revascularization

PROCEDURE

Angio-guided surgical revascularization

Sponsors & Collaborators

  • Abbott Medical Devices

    collaborator INDUSTRY

  • Portuguese Society of Cardiology

    lead OTHER

Principal Investigators

  • Ruben Ramos, MD · Hospital Santa Marta, Centro Hospitalar Lisboa Central

  • Sergio Batista, MD · Hospital Fernando da Fonseca

  • Luis Raposo, MD · Hospital de Santa Cruz, Centro Hospitalar de Lisboa Central

  • Emanuele Barbato, PhD · Olzv-Aalst Clinic

  • Colin Berry, PhD · Golden Jubilee National Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2021-01-31
Completion
2021-08-31

Countries

  • Portugal

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02173860 on ClinicalTrials.gov